Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF)

AIMS: Recurrent hospitalizations are a major part of the disease burden in heart failure (HF), but conventional analyses consider only the first event. We compared the effect of sacubitril/valsartan vs. enalapril on recurrent events, incorporating all HF hospitalizations and cardiovascular (CV) deat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Heart Fail
Päätekijät: Mogensen, Ulrik M., Gong, Jianjian, Jhund, Pardeep S., Shen, Li, Køber, Lars, Desai, Akshay S., Lefkowitz, Martin P., Packer, Milton, Rouleau, Jean L., Solomon, Scott D., Claggett, Brian L., Swedberg, Karl, Zile, Michael R., Mueller‐Velten, Guenther, McMurray, John J.V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Ltd 2018
Aiheet:
Focus on Prognostic Variables
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607507/
https://ncbi.nlm.nih.gov/pubmed/29431251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.1139
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia